Supply of Alumina and Magnesium Carbonate Tablets (Pharmaceutical Manufacturing)

The contract entails the manufacture and supply of pharmaceutical-grade alumina and magnesium carbonate tablets in bulk packaging, strictly adhering to the National Drug Code NDC 00766-1173-25 and all applicable commercial pharmaceutical standards. The production must meet rigorous quality control requirements to ensure consistency, purity, and compliance with regulatory expectations for pharmaceutical inputs. The items are intended for use in federal health and medical applications under the auspices of the Defense Logistics Agency, part of the Department of Defense, with the North American Industry Classification System code 325412 indicating classification under pharmaceutical and medicinal preparation manufacturing. This is a subcontract agreement, posted on August 5, 2026, and linked to the prime contract SPE2DX25D9900 with delivery order SPE2DP26F8778. While specific performance locations and point of contact details are not provided, the scope implies end-to-end responsibility for production, packaging, and delivery in bulk quantities without retail or individual unit packaging. The contract is not subject to a specified small business set-aside, and all work must be completed in alignment with federal pharmaceutical procurement protocols. The supplier is expected to maintain full traceability, documentation, and compliance throughout the manufacturing lifecycle to support defense medical supply chain integrity.